577 - Data-driven respiratory signal estimation from finely sampled projection data in conventional cardiac perfusion SPECT imaging. (ID 253) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

577 - Data-driven respiratory signal estimation from finely sampled projection data in conventional cardiac perfusion SPECT imaging. (ID 253)

Physics, Instrumentation & Data Sciences -> Image Generation 577

577 - Data-driven respiratory signal estimation from finely sampled projection data in conventional cardiac perfusion SPECT imaging. (ID 253)

Session Name

SPECT, Image Quality, Therapy

Speakers

P. Pretorius

Authors

Presentation Topic

Physics, Instrumentation & Data Sciences -> Image Generation

Presentation Number

577

Previous Eposter

576 - 3D Structural Convolutional Sparse Coding for PET Image Reconstruction (ID 258)

Next Eposters

580 - Evaluation of Methods to Decrease Formation of a Higher Molecular Weight Species When²¹¹At-Labeling of Antibody-B10 Conjugates Using Chloramine-T as Oxidant (ID 1244)

581 - N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[¹³¹I]iodobenzmide ([¹³¹I]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments. (ID 1243)

583 - Nucleophilic radiofluorination of aryl halides with K¹⁸F mediated by well-defined copper complexes (ID 1242)

585 - ¹⁸F-Radiofluorination of Aryl C-H Bonds using a Tandem Ir C-H Borylation/Cu Radiofluorination Strategy (ID 1241)

586 - A general ¹¹C-carboxylation approach mediated by fluoride-desilylation of organosilanes (ID 1239)

587 - MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer (ID 1246)

588 - ¹⁷⁷Lu-EB-PSMA radioligand therapy with escalating doses in patients with metastatic castration-resistant prostate cancer (ID 771)

590 - Interim Assessment of Kidney Dosimetry and Pharmacokinetics in a Phase I Study of CTT1403, a novel ¹⁷⁷Lu-labeled Small Molecule Inhibitor of Prostate Specific Membrane Antigen (ID 773)

591 - Early prostate-specific antigen changes and clinical outcome following ¹⁷⁷Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer (ID 775)

593 - Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer: an international multicentre retrospective study (ID 777)